All providers, regardless of where they work have a role in the shift to value-based care, but independent physicians need to have a voice in the transition, said Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
All providers, regardless of where they work have a role in the shift to value-based care, but independent physicians need to have a voice in the transition, said Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
Transcript
What role can independent physicians play in the transition to value-based care?
I think we all have challenges, whether we work in academic centers, or hospitals, or independent practices. I really believe though, as a private practice doctor, we have a chance to change the healthcare system. I think we can make a dent and start from there and grow this idea of going from fee-for-service to a value base.
I think independent physicians need to have a voice and pursue what is felt to be impossible. I think when we get together we know, we saw, what we can create together. We did little projects, we had fun doing it, we showed improvements in healthcare. Now we can grow and do it more globally and by bringing more practices together. I think that we will have a chance to do this without focusing on making millions of millions of dollars or flipping the organization into selling to something to make money.
The purpose is truly providing value-based care in our health system and helping the cost of this country’s huge expenditure in healthcare issues. And then providing the best care to our patients. I think we are able to do that, and I really believe we can get there.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Building Accountability Into GLP-1 Benefit Design: Lessons From Delaware and Philadelphia
August 20th 2025Employers explore glucagon-like peptide-1 (GLP-1) therapies' impact on health benefits, showcasing accountability and data-driven strategies in Philadelphia, Pennsylvania, and Wilmington, Delaware, for sustainable health programs.
Read More